• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Inc ALNY 3 Star

Last Price$124.88Day Change (%)0.75%
Open Price$124.42Day Change ($)0.93
Day Range123.09–125.9952-Week Range51.93–132.99

As of Thu 5/21/2015 5:00:00 PM | USD

  1. All
  2. 3rd Party
  1. Alnylam Files Clinical Trial Application (CTA) for ALN-AAT, an Investigational RNAi Therapeutic for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (Alpha-1 Liver Disease)

    Alnylam Files Clinical Trial Application (CTA) for ALN-AAT, an Investigational RNAi Therapeutic for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (Alpha-1 Liver Disease)

  2. BioMed Realty Trust Reports First Quarter 2015 Financial Results

    BioMed Realty Trust Reports First Quarter 2015 Financial Results

  3. Investing in Hidden Assets

    Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.